VIOCIN SULFATE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Viocin Sulfate, and what generic alternatives are available?
Viocin Sulfate is a drug marketed by Pfizer and is included in one NDA.
The generic ingredient in VIOCIN SULFATE is viomycin sulfate. There is one drug master file entry for this compound. Additional details are available on the viomycin sulfate profile page.
Summary for VIOCIN SULFATE
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 8 |
Patent Applications: | 39 |
Formulation / Manufacturing: | see details |
DailyMed Link: | VIOCIN SULFATE at DailyMed |
US Patents and Regulatory Information for VIOCIN SULFATE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Pfizer | VIOCIN SULFATE | viomycin sulfate | INJECTABLE;INJECTION | 061086-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Pfizer | VIOCIN SULFATE | viomycin sulfate | INJECTABLE;INJECTION | 061086-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |